Althobiani Malik A, Russell Anne-Marie, Jacob Joseph, Ranjan Yatharth, Ahmad Rami, Folarin Amos A, Hurst John R, Porter Joanna C
Department of Respiratory Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Respiratory Therapy Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Front Med (Lausanne). 2025 Feb 26;12:1361667. doi: 10.3389/fmed.2025.1361667. eCollection 2025.
This review provides a detailed overview of how digital health can be utilized in the management of Interstitial Lung Disease (ILD), and Chronic Obstructive Pulmonary Disease (COPD). ILD encompasses a diverse range of lung disorders characterized by inflammation and scarring of lung tissue, leading to restrictive lung physiology and impaired gas exchange, with symptoms including progressive dyspnoea, cough, and hypoxia. COPD which ranks as the third leading cause of death globally, is characterized by chronic lung inflammation causing irreversible airflow obstruction, recurrent exacerbations. While recent advances in digital health have shown promise, predicting disease progression in patients with ILD and exacerbation in patients with COPD remains challenging. This review explores the role of digital health in managing ILD and COPD, particularly focusing on telehealth and digital health technologies. Telehealth, defined broadly as the use of electronic information and telecommunications technologies in healthcare, has become increasingly relevant, especially during the COVID-19 pandemic. This review examines the role of digital health technologies in the management of ILD and COPD, with particular focus on telemedicine, and digital health tools. Remote monitoring technologies, including home spirometry and wearable devices, have demonstrated feasibility in managing respiratory diseases. However, challenges such as evidence, data reliability, varying adherence, education, and the high costs of data collection and lack of qualified clinicians present barriers for many national health systems.
本综述详细概述了数字健康如何用于间质性肺疾病（ILD）和慢性阻塞性肺疾病（COPD）的管理。ILD包括多种肺部疾病，其特征是肺组织炎症和瘢痕形成，导致限制性肺生理功能和气体交换受损，症状包括进行性呼吸困难、咳嗽和缺氧。COPD是全球第三大死因，其特征是慢性肺部炎症导致不可逆的气流阻塞和反复加重。虽然数字健康的最新进展已显示出前景，但预测ILD患者的疾病进展和COPD患者的病情加重仍然具有挑战性。本综述探讨了数字健康在ILD和COPD管理中的作用，特别关注远程医疗和数字健康技术。远程医疗广义上定义为在医疗保健中使用电子信息和电信技术，其相关性日益增加，尤其是在COVID-19大流行期间。本综述研究了数字健康技术在ILD和COPD管理中的作用，特别关注远程医疗和数字健康工具。包括家庭肺功能测定和可穿戴设备在内的远程监测技术已证明在管理呼吸系统疾病方面具有可行性。然而，诸如证据、数据可靠性、依从性差异、教育以及数据收集成本高昂和缺乏合格临床医生等挑战，给许多国家卫生系统带来了障碍。
